Back to News
Market Impact: 0.2
Bragar Eagel & Squire, P.C. Urges Capricor Therapeutics, Inc. Investors With Large Losses to Contact the Firm Before the September 28th Deadline
Source: globenewswire.com
Legal & LitigationHealthcare & Biotech
Bragar Eagel & Squire litigation partner Brandon Walker is soliciting Capricor Therapeutics (CAPR) investors who suffered losses to discuss potential legal options. The notice indicates potential investor litigation risk for the biotech company, though it provides no allegations, financial damages, case milestones, or operating updates.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly negative
Sentiment Score
-0.35
Ticker Sentiment
CAPR-0.75
More News
- World Leaders Converge on United Nations General Assembly
- Paramount and state AGs will settle lawsuit, allowing Warner Bros. merger to proceed, reports say
- Paramount settles with US states in step towards merger with Warner Bros
- Canada’s BC sues OpenAI over ChatGPT role in Tumbler Ridge school shooting
- GRAIL Stock Bounces Back Above $100: Can Galleri Sail Through Its FDA Panel Review?
- Meta's Muse personal AI agent tops ChatGPT, Grok and Claude for post-launch downloads
From AllMind Research
- Anthropic IPO Preview: Valuation, Timing, and What to Watch
- Shein After the IPO: Venue, Valuation, and What Must Be Proved
- What AI Research Tools Should a Small Hedge Fund Buy First?
- AI in Asset Management: 2026 Statistics That Hold Up
- What is Broker Research and RMS Systems (And How to Actually Use Them)